001452078 000__ 06356cam\a22006017i\4500
001452078 001__ 1452078
001452078 003__ OCoLC
001452078 005__ 20230310003339.0
001452078 006__ m\\\\\o\\d\\\\\\\\
001452078 007__ cr\cn\nnnunnun
001452078 008__ 230107s2022\\\\si\\\\\\o\\\\\001\0\eng\d
001452078 019__ $$a1363107050
001452078 020__ $$a9789811948008$$q(electronic bk.)
001452078 020__ $$a9811948003$$q(electronic bk.)
001452078 020__ $$z9789811947995
001452078 0247_ $$a10.1007/978-981-19-4800-8$$2doi
001452078 035__ $$aSP(OCoLC)1357017564
001452078 040__ $$aEBLCP$$beng$$erda$$cEBLCP$$dGW5XE$$dSFB$$dYDX
001452078 049__ $$aISEA
001452078 050_4 $$aRC600$$b.R65 2022
001452078 08204 $$a616.97/8$$223/eng/20230124
001452078 24500 $$aRole of microorganisms in pathogenesis and management of autoimmune diseases.$$nVolume II,$$pKidney, central nervous system, eye, blood, blood vessels and bowel /$$cMitesh Kumar Dwivedi, A. Sankaranarayanan, E. Helen Kemp, Yehuda Shoenfeld, editors.
001452078 24630 $$aKidney, central nervous system, eye, blood, blood vessels and bowel
001452078 264_1 $$aSingapore :$$bSpringer,$$c[2022]
001452078 300__ $$a1 online resource (538 p.)
001452078 336__ $$atext$$btxt$$2rdacontent
001452078 337__ $$acomputer$$bc$$2rdamedia
001452078 338__ $$aonline resource$$bcr$$2rdacarrier
001452078 500__ $$a4: The Protective Discourse Between Infections and Autoimmunity
001452078 500__ $$aIncludes index.
001452078 504__ $$aReferences -- 2: The Vaccines Induced Autoimmunity -- 2.1 Introduction -- 2.2 Vaccines -- 2.2.1 How Do Vaccines Work? -- 2.2.2 Types of Vaccines -- 2.2.2.1 Live Attenuated Vaccine -- 2.2.2.2 Inactivated Vaccine -- 2.2.2.3 Subunit and Conjugate Vaccines -- 2.2.2.4 Virus Like Particles -- 2.2.2.5 Viral Vector Vaccines -- 2.2.2.6 Nucleic Acid Vaccine -- 2.2.2.7 Toxoids -- 2.3 Autoimmune Diseases -- 2.3.1 Types of Autoimmune Disease -- 2.3.1.1 Systemic Autoimmune Disease -- 2.3.1.1.1 Rheumatoid Arthritis (RA) -- 2.3.1.1.2 Systemic Lupus Erythematosus -- 2.3.1.1.3 Multiple Sclerosis
001452078 5050_ $$aIntro -- Foreword -- Preface -- Contents -- Editors and Contributors -- Part I: Human Microbiome, Vaccines and Autoimmunity -- 1: Autoimmunity and Microbiome -- 1.1 Introduction -- 1.2 Microbiota and Immune System Interaction -- 1.3 Microbiota and Autoimmunity -- 1.4 Mechanisms of Autoimmunity Induced by Microbiota -- 1.4.1 Microbiome Translocation -- 1.4.2 Molecular Mimicry -- 1.4.3 Dysregulated Immune Response -- 1.4.3.1 Secretion of Immunosuppressive Cytokines -- 1.4.3.2 Cytolysis -- 1.4.3.3 Metabolic Disruption -- 1.4.3.4 Suppression of DC Maturation and Function -- 1.5 Conclusion
001452078 5058_ $$a2.3.1.1.4 Ankylosing Spondylitis -- 2.3.1.1.5 Scleroderma -- 2.3.1.1.6 Sjogrenś Syndrome -- 2.3.1.2 Organ-Specific Autoimmune Diseases -- 2.3.1.2.1 Type-1 Diabetes Mellitus (T1DM) -- 2.3.1.2.2 Hashimotoś Thyroiditis -- 2.3.1.2.3 Vitiligo -- 2.3.1.2.4 Graves ́Disease -- 2.3.1.2.5 Autoimmune Anemia -- 2.3.1.2.6 Goodpastureś Syndrome -- 2.3.1.2.7 Myasthenia Gravis -- 2.4 Mechanism of Vaccine Triggered Autoimmunity -- 2.4.1 Adjuvants -- 2.4.2 Molecular Mimicry -- 2.4.3 mRNA-Based Vaccines: a Trigger to Autoimmunity -- 2.4.4 Other Mechanisms -- 2.5 Vaccines Reported for Development of Autoimmunity
001452078 5058_ $$a2.5.1 Hepatitis B Vaccines -- 2.5.2 Measles, Mumps, and Rubella (MMR) Vaccines -- 2.5.3 Influenza Vaccine -- 2.5.4 Human Papilloma Virus (HPV) Vaccine -- 2.5.5 SARS-CoV-2 Vaccines -- 2.5.6 Other Vaccines -- 2.6 Conclusions -- References -- 3: COVID-19 and Autoimmunity -- 3.1 Introduction -- 3.2 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) -- 3.3 Virus Infection and Autoimmunity -- 3.3.1 SARS-CoV-2 Induced Autoimmunity -- 3.3.1.1 Molecular Mimicry -- 3.3.1.2 Bystander Activation -- 3.3.1.3 Cytokine Storm -- 3.3.1.4 Autoantibodies -- 3.3.1.5 Innate Immune Mechanisms
001452078 5058_ $$a3.3.1.6 Genetic Susceptibility -- 3.4 Similarities Between COVID-19 Manifestations and Autoimmunity -- 3.5 Autoimmune Complications of COVID-19 -- 3.5.1 Guillain-Barre Syndrome -- 3.5.2 Immune Thrombocytopenic Purpura -- 3.5.3 Kawasaki Disease -- 3.5.4 Autoimmune Thyroid Diseases -- 3.5.5 Rheumatoid Arthritis -- 3.5.6 Systemic Lupus Erythematosus -- 3.5.7 Type 1 Diabetes -- 3.5.8 Vitiligo -- 3.5.9 Alopecia areata -- 3.5.10 Cold Agglutinin Syndrome (CAS) -- 3.5.11 Antiphospholipid Syndrome -- 3.6 Autoimmune Disease: A Risk Factor for Severe COVID-19? -- 3.7 Conclusions -- References
001452078 506__ $$aAccess limited to authorized users.
001452078 520__ $$aThis book in the two volume set provides comprehensive coverage on how microbial pathogens can subvert our immune system into responding against self and resulting into autoimmune diseases. In particular, the book covers the different aspects of linking gut microbiota dysbiosis with autoimmune mechanisms involved in disease development to identify future effective approaches based on the gut microbiota for preventing these autoimmune diseases. Contributions in the book focuses on the role of microbiota/probiotics and their distinct mechanisms exerted in management of autoimmune liver, skin, thyroid, rheumatic and myopathic diseases. This could help in better understanding to design therapeutic strategies that can be deployed to prevent these autoimmune diseases. The book has an interdisciplinary appeal and scholars with an interest immunology, medical microbiology and nutritional sciences will value its contribution. Overall, the book gives a new dimensions and insight in the aspects of microbial role in autoimmune disease pathogenesis and therapeutic aspects.
001452078 588__ $$aDescription based on online resource; title from digital title page (viewed on January 31, 2023).
001452078 650_0 $$aAutoimmune diseases$$xPathogenesis.
001452078 650_0 $$aAutoimmune diseases$$xTreatment.
001452078 650_0 $$aMicrobial ecology.
001452078 655_0 $$aElectronic books.
001452078 7001_ $$aDwivedi, Mitesh Kumar,$$eeditor.
001452078 7001_ $$aSankaranarayanan, A.,$$eeditor.
001452078 7001_ $$aKemp, E. Helen,$$eeditor.
001452078 7001_ $$aShoenfeld, Yehuda,$$d1948-$$eeditor.
001452078 77608 $$iPrint version:$$aDwivedi, Mitesh Kumar$$tRole of Microorganisms in Pathogenesis and Management of Autoimmune Diseases$$dSingapore : Springer,c2023$$z9789811947995
001452078 852__ $$bebk
001452078 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-19-4800-8$$zOnline Access$$91397441.1
001452078 909CO $$ooai:library.usi.edu:1452078$$pGLOBAL_SET
001452078 980__ $$aBIB
001452078 980__ $$aEBOOK
001452078 982__ $$aEbook
001452078 983__ $$aOnline
001452078 994__ $$a92$$bISE